Prediagnostic Levels of Carcinoembryonic Antigen and CA 242 in Colorectal Cancer: A Matched Case-Control Study

Diseases of the Colon and Rectum

Volumn 46, Issue 11, 2003, Pages 1538-1544

  Palmqvist, Richard ^a   Engarås, Boel ^c   Lindmark, Gudrun ^d   Hallmans, Göran ^a   Tavelin, Björn ^a   Nilsson, Olle ^e   Hammarström, Sten ^a   Hafström, Larsolof ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^d HELSINGBORG HOSPITAL   (Sweden)

^e Fujirebio Diagnostics Inc   (Sweden)

Author keywords

CA 242; Carcinoembryonic antigen; Colorectal cancer; Northern Sweden Health and Disease Cohort; Tumor markers

Indexed keywords

CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0242594529     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6810-z     Document Type: Article

References (37)

1. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122:467-81.
2. American Society of Clinical Oncology. 1997 update of recommendations for the use tumour markers in breast and colorectal cancer. J Clin Oncol 1998;16:793-5.
3. Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbemaa JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219:174-82.
4. Graham R, Wang S, Catalano P, Haller D. Postsurgical surveillance of colon cancer. Preliminary cost analysis of physical examination, carcinoembryonic antigen testing, chest x-ray and colonoscopy. Ann Surg 1998; 228:59-63.
5. Chapman MA, Buckley D, Henson DB, Armitage NC. Preoperative carcinoembryonic antigen is related to tumor long-term survival in colorectal cancer. Br J Cancer 1998;78:1346-9.
6. Quentmeier A, Schlag P, Hohenberger P, Schwarz V, Abel U. Assessment of serial carcinoembryonic antigen: determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy. J Surg Oncol 1989;40:112-8.
7. Engarås B. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity. Dis Colon Rectum 2003;46: 313-21.
8. Engarås B, Kewenter J, Nilsson O, Wedel H, Hafström L. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease. Eur J Surg Oncol 2001;27:43-8.
9. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
10. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Sem Cancer Biol 1999; 9:67-81.
11. Beauchemin N, Draber P, Dveksler G, et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999;252:243-9.
12. Matsuoka Y, Matsuo Y, Okamoto N, Kuroki M, Kuroki M, Ikehara Y. Highly effective extraction of carcinoembryonic antigen with phosphatidylinositol-specific phospholipase C. Tumor Biol 1991;12:91-8.
13. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989;57:327-34.
14. Öbrink B. CEA adhesion molecules: multifunctional proteins with signal-regulatory properties. Curr Opin Cell Biol 1997;9:171-7.
15. Hammarström S, Baranov V. Is there a role for CEA in innate immunity in the colon? Trends Microbiol 2001;9: 119-25.
16. Baranov V, Yeung MM, Hammarström S. Expression of carcinoembryonic antigen and nonspecific cross-reactive 50 kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies. Cancer Res 1994;54: 3305-14.
17. Frängsmyr L, Baranov V, Hammarström S. Four carcinoembryonic antigen (CEA) subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in normal human colon epithelium are integral components of the fuzzy coat. Tumor Biol 1999;20:277-92.
18. Tibbetts LM, Doremus CM, Tzanakakis GN, Vezeridis MP. Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer 1993;71:315-21.
19. Steele G Jr, Zamcheck N. The use of CEA in the clinical management of patients with colorectal cancer. Cancer Detect Prev 1985;8:421-7.
20. Bormer OP, Paus E, Nustad K. Tumour markers as seen from the clinical laboratory: physiological, biochemical and analytical aspects. Scand J Clin Lab Invest 1991; 206(Suppl):12-20.
21. Johansson C, Nilsson O, Bäckström D, Janson EL. Novel epitopes on the CA50-carrying antigen: chemical and immunochemical studies. Tumor Biol 1991;12:159-79.
22. Nilsson O, Glimelius B, Persson B, Nörgaard-Pedersen B, Andrén-Sandberg Å, Lindholm L. Sensitivity and specificity of CA 242 in gastrointestinal cancer. A comparison with CEA, CA50 and CA19-9. Br J Cancer 1992; 65:215-21.
23. von Kleist S, Hesse Y, Kananeeh R. Comparative evaluation of four tumour markers, CA 242, CA19-9, TPA and CEA in carcinomas of the colon. Anticancer Res 1996;16:2325-32.
24. Carpelan-Holmström M, Haglund C, Lundin J, Alfthan H, Stenman UH, Roberts PJ, Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer 1996;74:925-9.
25. Scott NA, Wieand HS, Moertel CG, Cha SS, Beart RW, Lieber MM. Dukes' Stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 1987;122:1375-9.
26. Rognum TO, Heier HE, Orjasaeter H, Thorud E, Brandtzaeg P. Comparison of two CEA assays in primary and recurrent large bowel carcinoma with different ploidy pattern. Eur J Cancer Clin Oncol 1986;22: 1165-9.
27. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
28. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348: 1472-7.
29. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348: 1467-71.
30. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahren C. Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing. Results for 68, 308 subjects. Scand J Gastroenterol 1994;29:468-73.
31. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
32. Weinehall L, Johnson O, Jansson JH, et al. Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from northern Sweden. J Intern Med 1998;243:99-107.
33. Engarås B, Hafström L, Kewenter J, Nilsson O, Wedel H. Standard serum concentrations and normal fluctuations of CEA, CA 50 and CA 242 during twelve months in men and women aged 60-64 years without malignant disease. Eur J Surg 1999;165:110-6.
34. Lindmark G, Bergström R, Påhlman L, Glimelius B. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer 1995;71:1090-4.
35. Palmqvist R, Stenling R, Öberg Å, Landberg G. Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 1998;34:1575-81.
36. Goslin R, O'Brien MJ, Steele G, et al. Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981;71:246-53.
37. Komoto K, Furui J, Haraguchi M, Kanematsu T. The detection of colorectal cancer at an asymptomatic stage by screening is useful. Hepatogastroenterology 2000;47: 1011-4.